Ahead of her presentation at JP Morgan, Pharmaceutical Technology spoke with Dr. Jennifer Levin Carter, MD, founder and CEO ...
Atkins is leveraging a partnership with reality TV star Heather Gay and early clinical trial data to reposition nutrition as ...
Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences ...
Shanghai Henlius Biotech, Inc. announced that it entered into an exclusive global license agreement with U-mab Biopharma ...
Despite pledges to lower drug costs through Trump-backed pricing deals and direct-to-patient programs, pharmaceutical ...
Jeff Liter, CEO of Luminary Therapeutics, discusses the importance of demonstrating clinical evidence at the JP Morgan ...
PE: Were companies focused on demonstrating their expanded pipelines at this year’s JP Morgan Healthcare Conference? Keller: The lifeblood of everything we do is new clinical data. For us, its new ...
Pharmaceutical Executive: What was Daiichi Sankyo's strategy for preparing for the JP Morgan Healthcare Conference? Ken ...
Hayley Burgess SVP, Inovalon, talks about how specialty pharmacists are evolving from dispensers into precision-care partners ...
Regeneron's strategy focuses on a broad pipeline across six therapeutic areas, with significant near-term data readouts ...
Moderna CEO Stéphane Bancel positions 2026 as a catalyst-rich year driven by new vaccine launches, late-stage oncology data, ...
AbbVie is focused on pipeline expansion and diversification to address the upcoming patent cliff, with significant financial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback